Succinobucol-eluting stents increase neointimal thickening and peri-strut inflammation in a porcine coronary model.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
Jonathan WattKeith G Oldroyd

Abstract

The aim of this study was to assess the efficacy of stent-based delivery of succinobucol alone and in combination with rapamycin in a porcine coronary model. Current drugs and polymers used to coat coronary stents remain suboptimal in terms of long term efficacy and safety. Succinobucol is a novel derivative of probucol with improved antioxidant and anti-inflammatory properties. Polymer-free Yukon stents were coated with 1% succinobucol (SucES), 2% rapamycin (RES), or 1% succinobucol plus 2% rapamycin solutions (SucRES) and compared with a bare metal stent (BMS). The in vivo release profile of SucES indicated drug release up to 28 days (60% drug released at 7 days); 41 stents (BMS, n = 11; SucES, n =10; RES, n = 10; SucRES, n = 10) were implanted in the coronary arteries of 17 pigs. After 28 days, mean neointimal thickness was 0.31 ± 0.14 mm for BMS, 0.51 ± 0.14 mm for SucES, 0.19 ± 0.11 mm for RES, and 0.36 ± 0.17 mm for SucRES (P < 0.05 for SucES vs. BMS). SucES increased inflammation and fibrin deposition compared with BMS (P < 0.05), whereas RES reduced inflammation compared with BMS (P < 0.05). In this model, stent-based delivery of 1% succinobucol using a polymer-free stent platform increased neointimal formation and infl...Continue Reading

References

Oct 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·C RogersE R Edelman
Jul 25, 1998·The American Journal of Cardiology·M SekiyaH Akutsu
Feb 3, 1999·Annals of the New York Academy of Sciences·V E Kagan, Y Y Tyurina
May 23, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·Y ShiA Zalewski
Aug 17, 2002·Bioorganic & Medicinal Chemistry Letters·Charles Q MengMartin A Wasserman
Oct 3, 2002·Circulation·Robert S SchwartzUNKNOWN Consensus Committee
Nov 12, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Frederick G P Welt, Campbell Rogers
Nov 28, 2002·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Moo Hyun KimJong Seong Kim
Feb 5, 2003·Circulation·Jean-Claude TardifUNKNOWN Canadian Antioxidant Restenosis Trial (CART-1) Investigators
Mar 11, 2003·The Journal of Pharmacology and Experimental Therapeutics·Cynthia L SundellUday Saxena
Nov 18, 2003·The Journal of Pharmacology and Experimental Therapeutics·Charles KunschRussell M Medford
Apr 20, 2004·Japanese Heart Journal·Takayuki YokoyamaHiroyuki Daida
Aug 13, 2004·Cardiovascular Research·Andrew J CarterRobert Falotico
Feb 1, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Rainer WesselyAlbert Schömig
Jun 25, 2005·European Heart Journal·Jörg HausleiterUNKNOWN investigators of the individualizable durg-eluting Stent System to Abrogate Restenosis Project
Jan 5, 2006·Circulation·Julinda MehilliUNKNOWN Intracoronary Stenting and Angiographic Restenosis--Test Equivalence Between 2 Drug-Eluting Stents (ISAR-TEST) Trial Investi
Jul 4, 2006·Journal of the American College of Cardiology·Michael JonerRenu Virmani
May 19, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Aloke V FinnRenu Virmani
May 27, 2008·Lancet·Jean-Claude TardifUNKNOWN Aggressive Reduction of Inflammation Stops Events (ARISE) Trial Investigators
Apr 2, 2009·Expert Opinion on Investigational Drugs·Kendrea M Muldrew, Amy M Franks

❮ Previous
Next ❯

Citations

Jul 16, 2013·International Journal of Pharmaceutics·Rajesh ThipparaboinaAbraham J Domb
Sep 20, 2015·Annals of Biomedical Engineering·C M McKittrickC McCormick
Sep 30, 2016·Platelets·Stephanie A HoustonSimon Kennedy
Jun 24, 2016·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Grigorios TsigkasDimitrios Alexopoulos
Aug 12, 2017·Drug Delivery and Translational Research·Nagavendra KommineniAbraham J Domb
Aug 16, 2017·BMC Cardiovascular Disorders·Bin ZhangMing Chen
May 22, 2018·Current Atherosclerosis Reports·Paola Toledo-Ibelles, Jaime Mas-Oliva

❮ Previous
Next ❯

Methods Mentioned

BETA
NMR
scanning electron microscopy
sedation

Software Mentioned

Pro Plus
SPSS
Image

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
James J KleinedlerTammy R Dugas
Journal of Controlled Release : Official Journal of the Controlled Release Society
Kinam Park
© 2021 Meta ULC. All rights reserved